Global Blood Therapeutics (GBT) Files $250M Mixed Securities Shelf

October 14, 2016 6:07 AM EDT
Get Alerts GBT Hot Sheet
Trade GBT Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Global Blood Therapeutics (Nasdaq: GBT) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Add Your Comment